These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2655692)

  • 41. Metabolic effects of antihypertensive therapy with a calcium antagonist.
    Pool PE; Herron JM; Rosenblatt S; Reeves RL; Nappi JM; Staker LV; DiPette DJ; Evans RR
    Am J Cardiol; 1988 Oct; 62(11):109G-113G. PubMed ID: 3051991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides.
    Ames RP
    Am J Cardiol; 1996 Feb; 77(6):12b-16b. PubMed ID: 8848987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxprenolol slow-release with cyclopenthiazide KCl in the treatment of essential hypertension. A multicentre general practice study.
    Levenstein JH
    S Afr Med J; 1981 Jun; 59(25):893-9. PubMed ID: 7015537
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies on tienilic acid in hypertensive hyperuricaemic patients in Dunedin, New Zealand.
    Waal-Manning HJ; Bolli P; Wood AJ; Simpson FO
    Postgrad Med J; 1979; 55 Suppl 3():85-91. PubMed ID: 388401
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect on lipids, lipoproteins and apoproteins of labetalol prescribed in doses of 400 mg/day in hypertensive patients. Double-blind versus placebo study].
    Rouffy J; Bakir R; Chanu B; Djian F; Goy-Loeper J; Henry Amar M; Renon D; Pappo M
    Pathol Biol (Paris); 1986 Apr; 34(4):253-8. PubMed ID: 3529000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparative study of frusemide-amiloride and cyclopenthiazide-potassium chloride in the treatment of congestive cardiac failure in general practice.
    Crawford RJ; Allman S; Gibson W; Kitchen S; Richards HH
    J Int Med Res; 1988; 16(2):143-9. PubMed ID: 3378660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trimazosin for the treatment of hypertensive patients failing to respond to thiazides.
    Oberman A; Pool PE
    Am Heart J; 1983 Nov; 106(5 Pt 2):1258-64. PubMed ID: 6356855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial.
    Sorof JM; Cargo P; Graepel J; Humphrey D; King E; Rolf C; Cunningham RJ
    Pediatr Nephrol; 2002 May; 17(5):345-50. PubMed ID: 12042891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide.
    Raskin P; Guthrie R; Flack J; Reeves R; Saini R
    J Hum Hypertens; 1999 Oct; 13(10):683-7. PubMed ID: 10516738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antihypertensive treatment in postmenopausal women: results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide).
    Stimpel M; Koch B; Oparil S
    Cardiology; 1998 May; 89(4):271-6. PubMed ID: 9643274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Steady-state pharmacokinetics and pharmacodynamics of cilazapril in the presence and absence of cyclopenthiazide.
    Krum H; Jackson B; Conway EL; Howes LG; Johnston CI; Louis WJ
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):451-7. PubMed ID: 1279292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Additive hypotensive effect of a dihydropyridine calcium antagonist to that produced by a thiazide diuretic: a double-blind placebo-controlled crossover trial with ambulatory blood pressure monitoring.
    Stergiou GS; Malakos JS; Achimastos AD; Mountokalakis TD
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):412-6. PubMed ID: 9125681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antihypertensive and hypokalemic effects of isobutyl hydrochlorothiazide alone and in combination with spironolactone.
    Lochaya S; Suvachittanont O; Triyanond K
    J Med Assoc Thai; 1985 Aug; 68(8):399-407. PubMed ID: 3906011
    [No Abstract]   [Full Text] [Related]  

  • 58. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.
    Savage PJ; Pressel SL; Curb JD; Schron EB; Applegate WB; Black HR; Cohen J; Davis BR; Frost P; Smith W; Gonzalez N; Guthrie GP; Oberman A; Rutan G; Probstfield JL; Stamler J
    Arch Intern Med; 1998 Apr; 158(7):741-51. PubMed ID: 9554680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension.
    Pool JL; Guthrie RM; Littlejohn TW; Raskin P; Shephard AM; Weber MA; Weir MR; Wilson TW; Wright J; Kassler-Taub KB; Reeves RA
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):462-70. PubMed ID: 9607385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups.
    Pollare T; Lithell H; Mörlin C; Präntare H; Hvarfner A; Ljunghall S
    J Hypertens; 1989 Jul; 7(7):551-9. PubMed ID: 2668407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.